Your browser doesn't support javascript.
loading
How I treat inhibitors in haemophilia.
Makris, M; Hay, C R M; Gringeri, A; D'Oiron, R.
Afiliação
  • Makris M; Department of Cardiovascular Science, University of Sheffield, Royal Hallamshire Hospital, Sheffield, UK. m.makris@sheffield.ac.uk
Haemophilia ; 18 Suppl 4: 48-53, 2012 Jul.
Article em En | MEDLINE | ID: mdl-22726083
ABSTRACT
The management of patients with inhibitors is the greatest challenge facing haemophilia health professionals. Immune tolerance induction (ITI) can be successful in eliminating the inhibitor in the majority of patients, provided it is started soon after the inhibitor develops and the titre of the inhibitor is <10 BU at commencement of ITI. Acute bleeding is treated using one of two bypassing agents, which exhibit similar efficacy and safety. Surgery in inhibitor patients is challenging and should only be carried out in experienced centres.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator VIII / Coagulantes / Inibidores dos Fatores de Coagulação Sanguínea / Hemofilia A / Tolerância Imunológica Limite: Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator VIII / Coagulantes / Inibidores dos Fatores de Coagulação Sanguínea / Hemofilia A / Tolerância Imunológica Limite: Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article